Skip to main content
ANIK logo

ANIK

Anika Therapeutics, Inc.
$15.25 -0.57 (-3.60%) At close · Jul 17
Market Cap
$202.91M
Shares
13,305,624

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
57/100
Short interest 3.1% of shares — P60 Days to cover 4.9 — P79 Price vs VWAP +2.7% — P67 Short-volume trend -4.4% — P35 Short interest change -1.9% — P39 Worst FTD 0.01% of shares — P39

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 416,970 425,011 -8,041 4.89
2026-06-15 425,011 562,976 -137,965 7.06
2026-05-29 562,976 565,572 -2,596 7.87
2026-05-15 565,572 552,247 +13,325 5.41
2026-04-30 552,247 644,571 -92,324 4.28
2026-04-15 644,571 688,325 -43,754 4.87
2026-03-31 688,325 712,348 -24,023 5.47
2026-03-13 712,348 732,281 -19,933 4.85
2026-02-27 732,281 764,028 -31,747 5.08
2026-02-13 764,028 762,215 +1,813 4.36
2026-01-30 762,215 714,626 +47,589 5.78
2026-01-15 714,626 582,615 +132,011 5.59
2025-12-31 582,615 502,542 +80,073 3.58
2025-12-15 502,542 443,292 +59,250 2.99
2025-11-28 443,292 331,508 +111,784 2.45
2025-11-14 331,508 310,444 +21,064 2.10
2025-10-31 310,444 307,957 +2,487 3.24
2025-10-15 307,957 336,788 -28,831 3.44
2025-09-30 336,788 360,119 -23,331 2.77
2025-09-15 360,119 404,189 -44,070 4.65
2025-08-29 404,189 400,020 +4,169 3.30
2025-08-15 400,020 363,932 +36,088 3.05
2025-07-31 363,932 323,694 +40,238 2.37
Showing 1–23 of 23 settlements
Key facts CIK 898437 CUSIP 035255108 13F (30d) 11 filings 11 filers Visit website Investor relations